You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東方生物(688298.SH)突破300元創歷史新高 受益海外檢測試劑價格暴漲
格隆匯 01-10 15:50
格隆匯1月10日丨因海外檢測試劑價格暴漲,A股市場新冠檢測股集體收漲。其中,東方生物(688298.SH)盤中一度漲超13%至311.25元,再歷史新高價,最新收漲9.71%報300.6元,首次收於300元上方,市值361億元。 由於海外疫情嚴峻,目前全球新冠病毒檢測試劑盒需求激增導致價格上漲,部分市場價格翻倍。數據顯示,2021年4~5月份出口高峯期,浙江、福建和北京的出口量佔據前三位,三地的出口量基本相當,相差不大。而到了2021年下半年,我國檢測試劑的出口迅速向浙江企業集中。11月浙江的出口量幾乎相當於北京和福建4倍。據悉,主要是東方生物、奧泰生物和安旭生物3家公司出口大增,其中以東方生物貢獻最大。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account